| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology [R. M. M.] and Laboratory Medicine [A. M. P., F. W. S.], University of Connecticut Health Center, Farmington, Connecticut 06032
The interval between administration of carcinogen and development of sarcomas was significantly shorter in male Fischer rats that received bilateral injections into thigh muscles of a combination of 10 mg of Ni3S2 and 5 mg of 3,4-benzpyrene (Group C) than in rats that received only 10 mg of Ni3S2 (Group A) or only 5 mg of 3,4-benzpyrene (Group B). No sarcomas developed in control rats (Group D), which received only the injection vehicle (pencillin suspension). The period between injection of carcinogens and initial palpation of tumors at the injection sites averaged 18 ± 3 weeks in Group C versus 26 ± 5 weeks in Group A and 31 ± 10 weeks in Group B (p < 0.001). The period between injection of carcinogens and death from sarcoma averaged 24 ± 5 weeks in Group C versus 33 ± 5 weeks in Group A and 41 ± 11 weeks in Group B (p < 0.001). The proportion of primary sarcomas which were classified as rhabdomyosarcomas was 91% in Group C versus 81% in Group A and 13% in group B. This study furnishes (a) additional support for speculations concerning carcinogenic interaction between nickel compounds and polycyclic aromatic hydrocarbons and (b) a rapid and convenient experimental technique for inducing rhabdomyosarcomas in rats. This technique is well adapted for use as a laboratory exercise in neoplasia for pathology students.
1 Sponsored by United States Atomic Energy Commission Grant AT(30-1)4051; by USPHS Grant CA-11250 from the National Cancer Institute; and by United States Environmental Protection Agency Contract EHS-C-71-NEG-109.
2 To whom requests for reprints should be addressed at P. O. Drawer B, Newington, Conn. 06111.
Received 7/ 2/71. Accepted 7/29/71.
This article has been cited by other articles:
![]() |
T. Davidson, K. Salnikow, and M. Costa Hypoxia Inducible Factor-1{alpha}-Independent Suppression of Aryl Hydrocarbon Receptor-Regulated Genes by Nickel Mol. Pharmacol., December 1, 2003; 64(6): 1485 - 1493. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |